Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy

Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered. A 48-year-old woman presented at 17 6/7 weeks of gestation with vag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obstetrics and gynecology (New York. 1953) 2023-07, Vol.142 (1), p.211-214
Hauptverfasser: Applebaum, Jeremy, Mulugeta-Gordon, Lakeisha, Mokkarala, Sameera, Salva, Catherine R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 214
container_issue 1
container_start_page 211
container_title Obstetrics and gynecology (New York. 1953)
container_volume 142
creator Applebaum, Jeremy
Mulugeta-Gordon, Lakeisha
Mokkarala, Sameera
Salva, Catherine R.
description Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered. A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively. Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis.
doi_str_mv 10.1097/AOG.0000000000005214
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829425983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829425983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</originalsourceid><addsrcrecordid>eNpdkF1LwzAUhoMobk7_gUgvvenMR5O0l2PoJkw2cYJ3pU1OXbVrZtI69u_NPvzAQMg55D1v3jwIXRLcJziRN4PpqI__LE5JdIS6JJYspIy9HKMuxjQJZRxFHXTm3JsXEZGwU9RhkkUxTkQXPc7AlmYFNmvKTwiGpnal3nW-Cgpjg_HGNWBBNWa5Cco6eAJlah3ObbmE7U3wYKrMBjMLr3VWq805OimyysHF4eyh57vb-XAcTqaj--FgEirGaRT6JJpqpmKhmf-P4ILkOmGgEyEyzbmWOJeKaMpBCyW1Ak24knmBBRWxkqyHrve-K2s-Wh8lXZZOQVVlNZjWpTSmSUR5EjMvjfZSZY1zFop05dNndpMSnG5hph5m-h-mH7s6vNDmS9A_Q9_0fn3XpvIk3HvVrsGmC8iqZrHzE5TjkGLKsPRd6DeN2Be4Qn-5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829425983</pqid></control><display><type>article</type><title>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</title><source>Journals@Ovid Complete</source><creator>Applebaum, Jeremy ; Mulugeta-Gordon, Lakeisha ; Mokkarala, Sameera ; Salva, Catherine R.</creator><creatorcontrib>Applebaum, Jeremy ; Mulugeta-Gordon, Lakeisha ; Mokkarala, Sameera ; Salva, Catherine R.</creatorcontrib><description>Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered. A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively. Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1097/AOG.0000000000005214</identifier><identifier>PMID: 37348096</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><ispartof>Obstetrics and gynecology (New York. 1953), 2023-07, Vol.142 (1), p.211-214</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</citedby><cites>FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37348096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Applebaum, Jeremy</creatorcontrib><creatorcontrib>Mulugeta-Gordon, Lakeisha</creatorcontrib><creatorcontrib>Mokkarala, Sameera</creatorcontrib><creatorcontrib>Salva, Catherine R.</creatorcontrib><title>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered. A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively. Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis.</description><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkF1LwzAUhoMobk7_gUgvvenMR5O0l2PoJkw2cYJ3pU1OXbVrZtI69u_NPvzAQMg55D1v3jwIXRLcJziRN4PpqI__LE5JdIS6JJYspIy9HKMuxjQJZRxFHXTm3JsXEZGwU9RhkkUxTkQXPc7AlmYFNmvKTwiGpnal3nW-Cgpjg_HGNWBBNWa5Cco6eAJlah3ObbmE7U3wYKrMBjMLr3VWq805OimyysHF4eyh57vb-XAcTqaj--FgEirGaRT6JJpqpmKhmf-P4ILkOmGgEyEyzbmWOJeKaMpBCyW1Ak24knmBBRWxkqyHrve-K2s-Wh8lXZZOQVVlNZjWpTSmSUR5EjMvjfZSZY1zFop05dNndpMSnG5hph5m-h-mH7s6vNDmS9A_Q9_0fn3XpvIk3HvVrsGmC8iqZrHzE5TjkGLKsPRd6DeN2Be4Qn-5</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Applebaum, Jeremy</creator><creator>Mulugeta-Gordon, Lakeisha</creator><creator>Mokkarala, Sameera</creator><creator>Salva, Catherine R.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230701</creationdate><title>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</title><author>Applebaum, Jeremy ; Mulugeta-Gordon, Lakeisha ; Mokkarala, Sameera ; Salva, Catherine R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Applebaum, Jeremy</creatorcontrib><creatorcontrib>Mulugeta-Gordon, Lakeisha</creatorcontrib><creatorcontrib>Mokkarala, Sameera</creatorcontrib><creatorcontrib>Salva, Catherine R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Applebaum, Jeremy</au><au>Mulugeta-Gordon, Lakeisha</au><au>Mokkarala, Sameera</au><au>Salva, Catherine R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>142</volume><issue>1</issue><spage>211</spage><epage>214</epage><pages>211-214</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><abstract>Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered. A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively. Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>37348096</pmid><doi>10.1097/AOG.0000000000005214</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0029-7844
ispartof Obstetrics and gynecology (New York. 1953), 2023-07, Vol.142 (1), p.211-214
issn 0029-7844
1873-233X
language eng
recordid cdi_proquest_miscellaneous_2829425983
source Journals@Ovid Complete
title Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A37%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perioperative%20Considerations%20for%20Hysterectomy%20in%20Second-Trimester%20Molar%20Pregnancy&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Applebaum,%20Jeremy&rft.date=2023-07-01&rft.volume=142&rft.issue=1&rft.spage=211&rft.epage=214&rft.pages=211-214&rft.issn=0029-7844&rft.eissn=1873-233X&rft_id=info:doi/10.1097/AOG.0000000000005214&rft_dat=%3Cproquest_cross%3E2829425983%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2829425983&rft_id=info:pmid/37348096&rfr_iscdi=true